Pädiatrie up2date, Table of Contents Pädiatrie up2date 2014; 09(03): 231-244DOI: 10.1055/s-0034-1377341 Hämatologie/Onkologie © Georg Thieme Verlag KG Stuttgart · New York Angeborene Gerinnungsstörungen in der Pädiatrie Johannes Schelling , Barbara Zieger Recommend Article Abstract Podcasts Buy Article All articles of this category Full Text References Literatur 1 Hoppe F, Knuf M. Tonsillectomy and tonsillotomy: ENT surgeon and pediatric viewpoints. HNO 2013; 61: 173-185 2 Bowman M, Hopman WM, Rapson D et al. The prevalence of symptomatic von Willebrand disease in primary care practice. J Thromb Haemost 2010; 8: 213-216 3 Lillicrap D. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Blood 2013; 122: 3735-3740 4 Schneppenheim R, Budde U. Inborn and acquired von Willebrand disease. Hamostaseologie Review 2008; 28: 312-319 5 Castaman G, Montgomery RR, Meschengieser SS et al. von Willebrand's disease diagnosis and laboratory issues. Haemophilia 2010; 16 : 67-73 6 Nurden P, Nurden AT. Congenital disorders associated with platelet dysfunctions. Thromb Haemost 2008; 99: 253-263 Review 7 Streif W, Knöfler R, Eberl W et al. Leitlinie-Thrombozytopathien. Version 4.1; 30.10.2012. Im Internet: http://www.awmf.org/uploads/tx_szleitlinien/086-003l_S2k_Thrombozytopathien_2012-10.pdf Stand 19.5.2014 8 Sladky JL Klima J, Grooms L et al. The PFA-100 ® does not predict delta-granule platelet storage pool deficiencies. Haemophilia 2012; 18: 626-629 9 Naik S, Teruya J, Dietrich JE et al. Utility of platelet function analyzer as a screening tool for the diagnosis of von Willebrand disease in adolescents with menorrhagia. Pediatr Blood Cancer 2013; 60: 1184-1187 10 Seligsohn U. Treatment of inherited platelet disorders. Haemophilia 2012; 18: 161-165 11 Gouw SC, van den Berg HM, Oldenburg J et al. F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis. Blood 2012; 119: 2922-2934 12 Richards M, Lavigne LissaldeG, Combescure C et al. European Haemophilia Treatment and Standardization Board. Neonatal bleeding in haemophilia: a European cohort study. Br J Haematol 2012; 156: 374-382 13 Berger K, Schopohl D, Eheberg D et al. Treatment of children with severe haemophilia A and inhibitors: a health economic evaluation for Germany. Klin Padiatr 2013; 225: 152-158 14 Leissinger C, Carcao M, Gill JC et al. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders. Haemophilia 2014; 20: 158-167 15 Kurnik K, Auerswald G, Kreuz W. Inhibitors and prophylaxis in paediatric haemophilia patients: Focus on the German experience. Thromb Res 2013; 16 Kreuz W, Escuriola-Ettingshausen C, Funk M et al. When should prophylactic treatment in patients with haemophilia A and B start? – The German experience. . Haemophilia 1998; 4: 413-417 17 James AH, Hoots K. The optimal mode of delivery for the haemophilia carrier expecting an affected infant is caesarean delivery. Haemophilia 2010; 16: 420-424 18 Ljung R. The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery. Haemophilia 2010; 16: 415-419 19 Gailani D, Renne T. The intrinsic pathway of coagulation: a target for treating thromboembolic disease?. J Thromb Haemost 2007; 5: 1106-1112 20 Kleinschnitz C, Stoll G, Bendszus M et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 2006; 203: 513-518 21 Duga S, Salomon O. Factor XI Deficiency. Semin Thromb Hemost 2009; 35: 416-425 22 Meeks SL, Abshire TC. Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment. Haemophilia 2008; 14: 1159-1163 23 Duckers C, Simioni P et al. Advances in understanding the bleeding diathesis in factor V deficiency. Br J Haematol 2009; 146: 17-26 24 Mariani G, Bernardi F. Factor VII Deficiency. Semin Thromb Hemost 2009; 35: 400-406 25 Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-1252 26 Di Minno MN, Dolce A, Mariani G et al. Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency. Thromb Haemost 2013; 109: 1051-1059 27 Peyvandi F, Duga S et al. Rare coagulation deficiencies. Haemophilia 2002; 8: 308-21 28 Ruiz-Saez A. Occurrence of thrombosis in rare bleeding disorders. Semin Thromb Hemost 2013; 39: 684-692 29 Peyvandi F. Epidemiology and treatment of congenital fibrinogen deficiency. Thromb Res 2012; 130 : 7-11 30 Hsieh L, Nugent D. Factor XIII deficiency. Haemophilia 2008; 14: 1190-1200 31 Levy JH, Greenberg C. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency. Transfusion 2013; 53: 1120-1131 32 Odame JE, Chan AK et al. Factor XIII deficiency management: a review of the literature. Blood Coagul Fibrinolysis 2014; 25: 199-205
